Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC

Clinical trial NCT04010357 · COMPLETED

Trial details

NCT number: NCT04010357
Sponsor: Case Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Small-cell Lung Cancer Large Cell Neuroendocrine Carcinoma of the Lung Extrapulmonary Small Cell Carcinoma

Start date: 2020-01-13
Primary completion: 2026-04-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.